0001720959-19-000002.txt : 20190906
0001720959-19-000002.hdr.sgml : 20190906
20190906145243
ACCESSION NUMBER: 0001720959-19-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190906
DATE AS OF CHANGE: 20190906
EFFECTIVENESS DATE: 20190906
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neumentum, Inc.
CENTRAL INDEX KEY: 0001720959
IRS NUMBER: 821679493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-335830
FILM NUMBER: 191079415
BUSINESS ADDRESS:
STREET 1: 252 COLORADO AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 9082396142
MAIL ADDRESS:
STREET 1: 252 COLORADO AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001720959
Neumentum, Inc.
252 COLORADO AVENUE
PALO ALTO
CA
CALIFORNIA
94301
908-239-6142
DELAWARE
None
None
Corporation
true
2017
Richard
Scott
Shively
c/o Neumentum, Inc.
252 Colorado Avenue
Palo Alto
CA
CALIFORNIA
94301
Executive Officer
Director
Joseph
Pergolizzi
c/o Neumentum, Inc.
252 Colorado Avenue
Palo Alto
CA
CALIFORNIA
94301
Director
Christine
Mikail
Cvijic
c/o Neumentum, Inc.
252 Colorado Avenue
Palo Alto
CA
CALIFORNIA
94301
Executive Officer
Director
Pedro
Granadillo
c/o Neumentum, Inc.
252 Colorado Avenue
Palo Alto
CA
CALIFORNIA
94301
Director
Ilona
Steigerwald
c/o Neumentum, Inc.
252 Colorado Avenue
Palo Alto
CA
CALIFORNIA
94301
Executive Officer
August
Moretti
c/o Neumentum, Inc.
252 Colorado Avenue
Palo Alto
CA
CALIFORNIA
94301
Director
Pharmaceuticals
Decline to Disclose
- 06b
true
0001720959-19-000001
2019-03-12
false
true
true
false
0
CIM Securities, LLC
120852
None
None
275 Madison Avenue
39th Floor
New York
NY
NEW YORK
10016
CA
CALIFORNIA
CT
CONNECTICUT
FL
FLORIDA
IL
ILLINOIS
MD
MARYLAND
MA
MASSACHUSETTS
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
PA
PENNSYLVANIA
SC
SOUTH CAROLINA
TX
TEXAS
WY
WYOMING
false
Arcadia Securities, LLC
44656
None
None
1370 Avenue of the Americas
29th Floor
New York
NY
NEW YORK
10019
CA
CALIFORNIA
CO
COLORADO
FL
FLORIDA
NY
NEW YORK
PA
PENNSYLVANIA
WA
WASHINGTON
false
7000000
3020000
3980000
No additional convertible notes are expected to be sold and the offering will expire on its terms on September 8, 2019.
false
36
420000
true
0
Commissions are a % of the total offering. Agent shall also receive a 7 yr warrant for 7% of the number of shares into which securities sold in the offering convert (or, a cash fee of 7% of the purchase price for the securities.)
930000
true
The amount reflected in this Item 16 includes only salary and consulting payments the Issuer anticipates making to the executive officers and certain directors listed in Item 3, and assumes the Company raises the entire $7MM.
false
Neumentum, Inc.
R. Scott Shively
R. Scott Shively
Chief Executive Officer
2019-09-06